Guru Ownership Trend
Guru Analysis for Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11.27 M.
Top institutional holders include Renaissance Technologies (RenTech) and David Einhorn.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $44.39 M net outflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Immunovant, Inc. (IMVT)
Major holders include Renaissance Technologies (RenTech) ($4.78 M), David Einhorn ($2.32 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 286,020 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $44.39 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited IMVT. The total reported sell value was $51.49 M.
Yes, 2 managers opened new positions in IMVT, and 0 increased their existing holdings. The total reported buy value was $7.1 M.